{"DataElement":{"publicId":"7335602","version":"1","preferredName":"PET Positive For Extrapelvic Metastasis Stratification Factors Category","preferredDefinition":"A response used to determine the selected pre-treatment factors by which patients that are PET positive for extra-pelvic metastases are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"7335597v1.0:7335599v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"7335597","version":"1","preferredName":"Positron Emission Tomography Positive Finding For Extrapelvic Metastasis Stratification Factors","preferredDefinition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered._A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism._The reason of something._Situated outside of the pelvis._The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor._Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"2230940v1.0:7335595v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2230940","version":"1","preferredName":"Positron Emission Tomography","preferredDefinition":"A noninvasive imaging method that provides information about cellular activity (metabolic information).  It is used along with magnetic resonance imaging (MRI) which provides information about the shape and size of the tumor (spatial information).","longName":"C17007","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7C5DB4E-AC57-18B5-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-24","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-05-24","modifiedBy":"ONEDATA","dateModified":"2005-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7335595","version":"1","preferredName":"Positive Finding For Extrapelvic Metastasis Stratification Factors","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.:The reason of something.:Situated outside of the pelvis.:The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.:Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"7335595v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Extrapelvic","conceptCode":"C172875","definition":"Situated outside of the pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification Factors","conceptCode":"C16153","definition":"Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84BD04E-AA1C-0542-E053-4EBD850AAF35","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"ONEDATA","dateModified":"2020-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84BD04E-AA2D-0542-E053-4EBD850AAF35","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeDescription":"Created for EA8191, 06/17/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7335599","version":"1","preferredName":"Scan Result Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"7335599v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N/A - PET Negative for Extra-Pelvic Metastases","valueDescription":"Not Applicable Positron Emission Tomography Negative Finding For Extrapelvic Metastasis","ValueMeaning":{"publicId":"7425502","version":"1","preferredName":"Not Applicable Positron Emission Tomography Negative Finding For Extrapelvic Metastasis","longName":"7425502","preferredDefinition":"Determination of a value is not relevant in the current context.: A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.: A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.: The reason of something.: Situated outside of the pelvis.: The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Extrapelvic","conceptCode":"C172875","definition":"Situated outside of the pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF83CE1C-E47D-2D3E-E053-4EBD850A4AFB","latestVersionIndicator":"Yes","beginDate":"2020-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-17","modifiedBy":"ONEDATA","dateModified":"2020-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF83CE1C-E498-2D3E-E053-4EBD850A4AFB","beginDate":"2020-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-17","modifiedBy":"ONEDATA","dateModified":"2020-09-17","deletedIndicator":"No"},{"value":"Greater than 5 extra-pelvic lesions","valueDescription":"Greater Than Five Extrapelvic Malignant Lesion","ValueMeaning":{"publicId":"7335601","version":"1","preferredName":"Greater Than Five Extrapelvic Malignant Lesion","longName":"7335601","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.: Situated outside of the pelvis.: A lesion characterized by the presence of a malignant cellular population.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Five","conceptCode":"C66836","definition":"A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Extrapelvic","conceptCode":"C172875","definition":"Situated outside of the pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Lesion","conceptCode":"C160776","definition":"A lesion characterized by the presence of a malignant cellular population.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84B10F3-E963-6074-E053-4EBD850AD280","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"ONEDATA","dateModified":"2020-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A84B10F3-E97E-6074-E053-4EBD850AD280","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"ONEDATA","dateModified":"2020-06-17","deletedIndicator":"No"},{"value":"Less than or equal to 5 extra-pelvic lesions","valueDescription":"Less Than or Equal To Five Extrapelvic Malignant Lesion","ValueMeaning":{"publicId":"7335606","version":"1","preferredName":"Less Than or Equal To Five Extrapelvic Malignant Lesion","longName":"7335606","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.: Situated outside of the pelvis.: A lesion characterized by the presence of a malignant cellular population.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than or Equal To","conceptCode":"C61586","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Five","conceptCode":"C66836","definition":"A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Extrapelvic","conceptCode":"C172875","definition":"Situated outside of the pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Lesion","conceptCode":"C160776","definition":"A lesion characterized by the presence of a malignant cellular population.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84C1997-7D00-1503-E053-4EBD850AE644","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"ONEDATA","dateModified":"2020-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A84C1997-7D1B-1503-E053-4EBD850AE644","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"ONEDATA","dateModified":"2020-06-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84B10F3-E948-6074-E053-4EBD850AD280","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"6013685","version":"1","longName":"Stratification Factor","context":"ECOG-ACRIN"}]}],"AlternateNames":[{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"PET Positive for Extra-Pelvic","type":"Preferred Question Text","description":"PET Positive for Extra-Pelvic Metastases","url":null,"context":"ECOG-ACRIN"},{"name":"NRG_Text","type":"Alternate Question Text","description":"Positive PET for extrapelvic nodal or soft tissue lesion as described in 3.1.6","url":null,"context":"NRG"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84BE682-9E38-35DE-E053-4EBD850AD02C","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"KENNISHM","dateModified":"2021-06-09","changeDescription":"Created for EA8191, 06/17/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}